ANSTO Nuclear Medicine: Reliable and Timely Mo-99 Supply Globally

Transcription

1 Presentation 8 Session 3 ANSTO Nuclear Medicine: Reliable and Timely Mo-99 Supply Globally Jayne Senior General Manager, ANSTO Nuclear Medicine Pty Ltd (ANM) Biography Jayne Senior is General Manager for ANSTO Nuclear Medicine (ANM) Pty Ltd, a subsidiary company of the Australian Nuclear Science and Technology Organisation (ANSTO) based in Sydney, Australia. Jayne is responsible for the overall management of both the current ANSTO Mo-99 business, as well as ANM, which is currently in the final stages of completion. Jayne was educated in the UK and holds an honours degree in Genetics, as well as two masters degrees in Clinical Genetics and Bio-Aeronautics. After a short period in research, Jayne moved into business and has held senior positions at director and executive level. She has worked across many markets and countries, within global multi-national as well as private companies operating in highly regulated industries such as pharmaceuticals and food Abstract ANSTO is in the latter stages of completion of a new Mo-99 manufacturing plant at its Lucas Heights Facility in Australia. Designed with an anticipated capacity of 3500 six-day Curies of Mo-99 per week, this new facility will contribute significantly to increased reliability of Mo- 99 supply globally. Furthermore, the facility has been designed to maximise production at peak demand times. This allows Mo-99 supply to best match customer requirements at the peak times in the week when it is required. In doing this, decay and therefore waste are both reduced. Key features of the new plant are LEU technology, utilisation of proven Mo-99 production technology and effective waste and environmental emissions control. Physical construction of the new facility is now finished, with commissioning planned for the latter half of Routine supply of Mo-99 globally is expected early A description of the project, the key design features and its current status will be provided. ANA2017 Conference, Sydney, 6 Oct

2 Reliable & Timely Global Supply of Molybdenum-99 ANA National Conference Sydney, October 2017 Jayne Senior

3 Agenda 1. ANM Project Background 2. ANM Design & Capacity 3. ANM Construction & Commissioning Status 4. SyMo

4 ANM Project Background

5 ANSTO Nuclear Medicine ANM

6 Molybdenum-99 Mo-99 is the precursor to Technetium-99m Tc-99m used in 80% of all nuclear medicine procedures Used for diagnosis of heart disease, cancer, neurological disorders and other conditions 40 million patient scans per year

7 Benefits to all Australians Ensuring local supply Manufacturing and job opportunities Global supply and health outcomes

8 Mo -99 World Supply LVR-15 Czech. 5% HFR Netherlands 40% Maria Poland 5% BR-2 Belgium 20% Ageing Ageing Closed NRU Canada 0% SAFARI 1 South Africa 15% OPAL Australia 15%

9 ANSTO Nuclear Medicine Operated as a subsidiary of ANSTO One product- Mo-99 Scalable domestic and worldwide supply Full lifecycle consideration

10 ANSTO Nuclear Medicine project TWO PARTS Mo-99 Facility ANM Synroc Waste Plant SyMo

11 Production and Waste Lifecycle

12 OPAL Mo-99 Plant ANM Synroc Waste Plant SyMo Lucas Heights Location

13 ANM Design & Capacity

14 ANSTO Nuclear Medicine project TWO PARTS Mo-99 Plant ANM Synroc Waste Plant SyMo 3,500 6 day Ci per week LEU fuel & LEU targets Base digestion process Proven, reliable technology Low emissions (Xe-133) Integrated preparation and testing labs

15 Integrated Mo-99 Production Cycle Plate target OPAL irradiation Plate transport Generator production Chemical separation ANM

16 ANM Mo-99 Production Process Plates Dissolution Filtering and separation Purification Conditioning Mo-99 Patient Waste streams

17 World Best Safety Features New production efficiencies throughout State of art hot cell design Separate hot cells for each process step Radiation shielding In-cell equipment back-up Best practice hot cell transfer system Extensive emission control systems

18 Capacity Increases Projection of 6-day Ci production/week ANM 10 runs x 12 plates Current Facility 4 runs x 8 plates Current Facility 5 runs x 12 plates Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q

19 ANM Capacity and Flexibility World demand Profile day Ci ANM supply profile day Ci % Demand 40 % Supply weekend rest of week 0 weekend rest of week

20 Construction & Commissioning Status

21 20 Before

22 After

23 Front entrance

24 Ramp to front entrance

25 Side access

26 Production cell face

27 Hydrogen cell face

28 Dissolution cell control panel

29 Waste handling cells

30 Rear of hot cells

31 Plant room

32 Rear of hot cells

33 Basement gas tanks

34 Basement iodine filters

35 QC intermediate sample test lab

36 Process preparation room

37 Mo-99 Facility Milestones Operation licence submission to ARPANSA Public consultation Construction complete Commissioning underway Active commissioning and operation COMMISSIONING ACTIVE COMMISSIONING APRIL 2017 JUNE 2017 JULY 2017 November/ December 2017 Subject to ARPANSA licence

38 SyMo

39 ANSTO Nuclear Medicine project TWO PARTS Mo-99 Plant ANM 3,500 6 day Ci per week LEU fuel & LEU targets Base digestion process Proven, reliable technology Low emissions (Xe-133) Integrated preparation and testing labs Synroc Waste Plant SyMo Hot isostatic press technology 320 cans produced per year Integrated with Mo-99 facility Treats intermediate level liquid waste Waste volume reduction by 90% Immobilised waste form

40 ANSTO Synroc: The Waste Solution Provides Australia with a plan for existing nuclear waste The safest and most economic method for dealing with waste in the long term Australian-owned intellectual property Technology utilised by ANM for SyMo plant

41 ANSTO Synroc Technologies - Status Extensive testing and qualification of chemical durability Appropriate technologies selected for processing of liquid ILW Designed and built replica pilot scale process line to convert liquid to powder Demonstrated HIP process with wasteform to final scale - 30L cans

42 Comparative Waste Volumes Cementation volume for interim storage Alkaline liquid waste per year 4m 3 Final disposal volume Cask HIPed CANs

43 Cementation transport per 10 years 1560 Tonnes (> 150 trucks) Disposal Volume of Waste ANSTO Synroc transport per 10 years 14 Tonnes

44 Hot Isostatic Pressing (HIP)

45 Synroc Cans Before and After HIP

46 SyMo Front View

47 SyMo Side View

48 SyMo Hot Cell

49 SyMo Pipe Installation

50 Thank You